(19) United States
`(12) Patent Application Publication (10) Pub. No.: US 2011/0218502 A1
`
` Iio et al. (43) Pub. Date: Sep. 8, 2011
`
`
`US 20110218502A1
`
`(54) CARRYING CASE AND SYRINGE SYSTEM
`WITH SAME
`
`(76)
`
`Inventors:
`
`Toshiaki Iio, Ehime (JP); Yukihiro
`Takabatake, Ehime (JP)
`
`(21) Appl. No.:
`
`13/128,940
`
`(22) PCT Filed:
`
`Oct. 2, 2009
`
`(86) PCT NO"
`§ 371 (c)(1)
`’
`(2): (4) Date:
`
`PCT/JP2009/005135
`
`May 12’ 2011
`
`(30)
`
`Foreign Application Priority Data
`
`Nov. 14, 2008
`
`(JP) ................................. 2008-292793
`
`Publication Classification
`
`(51)
`
`Int. Cl.
`(2006.01)
`A61M 5/178
`(2006.01)
`H02] 7/00
`(200601)
`A613 17/06
`(52) US. Cl. .......... 604/264; 320/107; 320/108; 206/438
`
`ABSTRACT
`(57)
`A carrying case (1) for a pharmaceutical injection device (21)
`administering a pharmaceutical to a living body includes a
`case unit (2, 20) and an electric charging device (3a). The case
`unit (2, 20) accommodates the pharmaceutical
`injection
`device (21). The electric charging device (3a) is mounted in
`the case unit (2, 20), includes an electric charging terminal (9)
`electrically connectable to the pharmaceutical
`injection
`device (21), and electrically charges the pharmaceutical
`injection device (21). The carrying case (1) can prevent
`troubles including such a situation that a user cannot charge
`the pharmaceutical injection device (21) while being outwith
`the carrying case.
`
` 1
`
`APPLE 1010
`
`1
`
`APPLE 1010
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 1 0f 30
`
`US 2011/0218502 A1
`
`20d
`
`(6
`
`ON
`
`50
`
`20b
`
`FIG.1
`
`2
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 2 0f 30
`
`US 2011/0218502 A1
`
`xxm
`00oM-
`
`FIG.2
`
`§\N\\\§%\\
`
`:1—
`\\Vfiim/K/AIKE[K
`§F
`§
`?\
`"\‘5
`
`9
`
`0
`
`3
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 3 0f 30
`
`US 2011/0218502 A1
`
`
`
`
`
`FIG.3A
`
`14
`
`
`
`FIG.3B
`
`4
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 4 of 30
`
`US 2011/0218502 A1
`
`momDOwmm.>>On_:_<_ON_m=>=>_OO
`
`
`03¢a?
`
`w.07.
`
`m3
`
`O<
`
`moE<o<
`
`
`
`
`
`
`
`moEmzzoommfizEa5&8E261
`
`Qm<OmH5015
`
`
`
`L____ ____.
`
`...................................._
`._<Z__>_mm._.OZ_Om<IOO_m._.0ml_m_-
`
`
`
`
`
`
`
`
`
`
`
`ZO_._.OmmOZ_._.<m_mn_OZ_<_>_
`
`><.Ew_DHDQZ
`
`.523.223
`
`mmX”
`
`mm
`
`R
`
`I8taoma
`
`memzmmwz_om<:o
`
`\/\E0520&5me
`
`IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
`
`
`
`
`mw>_momm._<Z__>_mm._.
`
`
`
`
`
`mfiimnommSaEOoomoSjmo
`
`>m<o200mm
`
`mm
`
`2
`
`5
`
`
`
`
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 5 0f 30
`
`US 2011/0218502 A1
`
`V“
`V“
`
`FIG.5
`
`6
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 6 of 30
`
`US 2011/0218502 A1
`
`o.0:L
`
`
`
`
`
`
`
`ZOFOm—wOZF<mmmoZ712
`
`
`
`><»_n_m_n_._.Dn_Z_
`
`.523.523
`
`
`
`mm«m
`
`5.328%
`
`mm
`
`
`
`
`
`mflimao$512889:.30
`
`
`
`
`
`momsowmm.>>On_._<_Omw_>=>_OO
`
`||v
`
`
`
`O<
`
`mOHm<0<
`
`mm
`
`m
`m
`
`
`
`mszmmE052
`
`
`
`OEHOmfim
`
`OZ_Om<IO
`
`.EDOEO
`
`
`
`7$28taoma
`
`
`
`
`DmFZEn.>n_n_n5mmm>>On_\/"/§m_‘
`
`7
`
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 7 0f 30
`
`US 2011/0218502 A1
`
`FIG.7
`
`8
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 8 of 30
`
`US 2011/0218502 A1
`
`
`
`
`
`03.2.0me
`
`OZ_OE<IO
`
`.EDOEO
`
`
`
`
`
`>m<DZOOmm
`Ijmo\./\
`
`MR
`
`jmo920m:Domam>m<§EBEE5&8E26;m
`
`me
`
`9
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 9 0f 30
`
`US 2011/0218502 A1
`
`26a
`
`FIG.9
`
`10
`
`10
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 10 of 30
`
`US 2011/0218502 A1
`
`OH.07.
`
`
`
`
`
`r..................m-mm---------HMMMM¥.............................
`
`
`
`><4umx_F3m2_
`
`:2::2:
`
`zOfiomwwzz<mm&u222mm
`
`
`
`
`
`mWmflimnommSazooomoi.30mm>m<ozoommm
`
`vm
`
`
`
`
`
`momDOwmm>>On_4<_Omm_>=>_00
`
` _0::
`
`mOHm<D<
`
`mm
`
`\IN._._m_0
`
`
`
`Dm<0m.EDOmzo
`
`:mOFOMZZOO
`
`IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
`
`>m<_>=ma
`
`
`
`
`
`
`
`DmFZEn.>..En_3wmm>>0n_
`
`mm
`
`mom
`
`3
`
`
`
`
`
`
`
`mm>_m0mm4<Z=2mmk
`
`mm
`
`
`
`momzmm>m02m2
`
`om
`
`
`
`OEHOMZM
`
`OZ.0K<IO
`
`.EDOEO
`
`mm
`
`ow
`
`11
`
`11
`
`
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 11 0f 30
`
`US 2011/0218502 A1
`
`259
`
`250
`
`253
`
`12
`
`C)
`
`NN
`
`12
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 12 0f 30
`
`US 2011/0218502 A1
`
`m N T
`
`—l
`
`L9
`
`1—4
`LI.
`
`<
`
`N 1
`
`-1
`
`0l
`
`---l
`LI.
`
`(U
`
`a
`
`«:04
`gag
`
`
`
`:
`
`3
`N
`
`l\
`LO
`N
`
`13
`
`13
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 13 0f 30
`
`US 2011/0218502 A1
`
`FIG.13
`CLEARANCEB
`
`U 0 Z < D
`
`< L
`
`C
`<1:
`LIJ
`.....J
`O
`
`14
`
`14
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 14 0f 30
`
`US 2011/0218502 A1
`
`FIG.14
`
`305g
`
`.3:
`LO
`“)
`
`OC
`
`xmmkmx :
`
`E
`
`[I
`
`lg:
`
`305f
`
`305e \
`
`n.
`
`305a
`
`305b
`
`305o
`
`305d
`
`303
`
`302
`
`15
`
`15
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 15 0f 30
`
`US 2011/0218502 A1
`
`FIG.15
`
`3059
`
`16
`
`16
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 16 0f 30
`
`US 2011/0218502 A1
`
`0 1
`
`-!
`
`L9I--l
`LI.
`
`m
`
`KO
`
`I
`L91-4
`L1.
`
`Ԥ
`
`%
`
`
`
`i-«v-«wm
`
`Wm mmay,“mymmva-MVM.W”WCg
`
`
`
`.AWAKV:;‘V.4~.WAV.-
`
`raver-saw;
`
`:2
`(\I
`
`a)
`
`8
`<0
`
`«if
`
`U.
`
`<1:
`LO
`1-1
`
`L9l--l
`
`17
`
`17
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 17 0f 30
`
`US 2011/0218502 A1
`
`
`
`u
`
`210 \ MAIN CIRCUIT
`
`
`
`INP T DEVI E
`U
`C
`
`215MEMORY
`
`217
`SENSOR
`
`
`
`221
`
`
`DISPLAY
`
`DEVICE
`
`216
`213
`
`DRIVE
`MICROCOMPUTER
`DEVICE
`
`
`ELECTRIC
`
`
`CHARGING
`
`218
`
`CIRCUIT
`
`
`COMMUNICATION
`
`UNIT
`
`
`
`
`
`
`
`
`
`
`
`
`MAIN CIRCUIT
`
`FIRST
`
`
`FIRST POWER
`COMMUNICATION
`
`
`
`4020
`
`SUPPLY CIRCUIT
`UNIT
`
`
`
`MICROCOMPUTER
`
`
`4025
`
`
`ELECTRIC
`SECOND
`
`
`
`CHARGING
`COMMUNICATION
`
`
`CIRCUIT
`UNIT
`
`4026
`
`
`
`DISPLAY UNIT
`
`
`
`
`
`
`4021
`
`
`4029
`POWER
`MEMORY
`
`VIBRATION
`GENERATING
`
`
`UNIT
`UN”
`
`4022
`
`
`OPEN/CLOSE DETECTION SW
`
`
`
`
`
`
`(LCD/LED)
`
`4027
`INPUT UNIT
`
`4028
`AUDIO UNIT
`
`
`
`
`
`
`
`
`
`4015
`
`1
`-
`40 6
`
`4017
`
`II
`
`4014 :\
`
`
`
`
`
`FROM COMMERCIAL POWER SOURCE
`
`
`
` STORAGE
`
`INPUT
`PERSONAL
`
`
`
`COMPUTER
`DEVICE
`DEVICE
`
`
`
`63
`62
`61
`
`
`FIG. 17
`
`18
`
`18
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 18 of 30
`
`US 2011/0218502 A1
`
`“529.51.1200
`
`
`
`0Z_0m<IOOEFOMIE
`
`HD0-0ZFI03
`
`02:.10:
`
`mem02_022.10:
`
`0Z_0m<IO
`
`OEFOMIEZOZmn~>._.Om:
`
`0Z_0m<IOOEHOmjm.
`
`
`0mmZ_022.103FDO-0ZEII0_._Om:EOAO0-0>>._.
`
`
`m0ZO_._.m._n=>_OOOEFOMAMOEHOmZmTZOZ
`
`
`0ZFI03HD0-0ZE.I0_._Om:mOgOO-m._0Z_m
`
`
`0222.15HDO-0ZE.I0_I_Om:mOAOO-m_._0Z_w
`
`
`O_m._.0m3m_0Z_0m<IO0Z_0M<IO
`
`moz<mo2.02:10:
`
`8mmoz<zmmmo
`
`15m2_@2onEV
`0mm2_02:10:
`
`
`
`mem0-Om:
`
`
`Z_0Z:.I03H3002:10:mOJO0-0>>._.
`
`LOZOEMEQEOO
`
`ZO_._.<0_ZD_>:>_OO
`
`02729232200
`
`
`
`
`
`
`
`DMPOMZZOODmHOMZZOOZDma>._.Om:
`
`02:.10:
`
`0Z§ZIm
`
`0Z_._.I0_._F3002:10:04025
`
`
`
`-Om:$0400
`
`ov
`
`19
`
`0Z~0M<IO
`
`
`
`mH6Hi5:;I._._>>DmCIMIEEOO
`
`
`
`51.1%I|_r_>>.333»
`
`ZOF<O_ZD_2_>_OO=
`
`
`
`
`
`02729232200:O._.szbmzzoo=><IEmE02
`
`ZO_._.<0_ZD
`
`“.0ZOEMIEEOO
`
`
`
`.22000Z_._.<O_ZD_>:>_OOQMPOMZZOODMFOMZZOOZDU
`
`
`
`
`
`Av
`
`19
`
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 19 0f 30
`
`US 2011/0218502 A1
`
`620
`
`674
`
`673 FIG.19
`
`NO(
`
`O
`
`20
`
`20
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 20 of 30
`
`US 2011/0218502 A1
`
`DON.DE
`
`wowmmaxNon
`
`Emcm6:
`
`E,<86:
`
`
`
`3K
`
`05
`
`2K
`
`we?
`
` rm
`
`21
`
`21
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 21 0f 30
`
`US 2011/0218502 A1
`
`_ 0
`-_1—|
`
`:N
`
`(DM
`
`‘LI_
`
`/8[\
`
`_cu
`(‘0
`0
`
`O0
`
`m
`1—:
`N
`.
`(D
`m
`
`(\l
`0
`
`O0
`
`
`
`o
`&
`
`5
`00
`
`2
`°°
`
`a
`
`
`
`<
`1-I
`N
`'
`L9
`U.
`
`
`
`
`885
`
`22
`
`22
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 22 0f 30
`
`US 2011/0218502 A1
`
`902
`
`FIG.220
`FIG.22A
`
`FIG.228
`
`23
`
`23
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 23 of 30
`
`US 2011/0218502 A1
`
`0mm.UE
`
`crow
`
`<mN.UE
`
`24
`
`24
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 24 of 30
`
`US 2011/0218502 A1
`
`No:
`
`ON:
`
`Xfififififififififi
`
`or:
`
`No:
`
`mwm.07.
`
`<VN.DE
`
`".5.
`
`a.
`
`a.
`
`‘5.
`
`rm
`
`5:
`
`ON:
`
`25
`
`25
`
`
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 25 0f 30
`
`US 2011/0218502 A1
`
`“208FIG.25C
`
`L0
`N
`I
`
`E
`
`S 3
`
`1202
`
`
`
`<
`L“
`N
`
`9
`
`U.
`
`gN
`
`V"
`
`Q g
`
`26
`
` 21C
`21 £0
`
`v.
`
`ONf
`
`...
`
`26
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 26 0f 30
`
`US 2011/0218502 A1
`
`0
`0
`
`N L
`
`9l--|
`U.
`
`D 5
`
`2'8
`r
`
` .\
`
`‘—
`
`N (
`
`U
`C")
`
`N
`N
`
`2
`
`E(
`
`’3
`F}
`
`E
`
`O Q"
`
`LO
`
`0 3
`
`3
`
`‘\A
`
`8
`
`/
`
`/
`
`m
`\O
`N
`
`D
`E
`
`NO S
`
`?
`
`ix.
`
`0 S
`
`2
`
`O 2
`
`..
`
`<
`0
`N
`
`2
`u.
`
`27
`
`27
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 27 0f 30
`
`US 2011/0218502 A1
`
`m
`E
`
`[20
`|\
`N
`
`9
`LI_
`
`N0 $
`
`2
`
`N
`O
`co
`
`2‘
`
`«5?,
`f?
`
`O l
`
`\
`(\I
`
`L9!—|
`L
`
`
`
`{U
`8
`3
`
`‘—
`N
`
`O‘
`
`—
`9
`
`Em
`
`‘_
`
`E
`
`0 gW
`
`W
`
`LO
`
`0 $
`
`2
`
`4%»
`mafiwmflmfl
`
`28
`
`
`
`<1:
`'\
`(\I
`
`g
`LI.
`
`N
`N
`
`$3
`
`28
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 28 0f 30
`
`US 2011/0218502 A1
`
`
`
`C]
`
`L9I—I
`LL.
`
`
`
`N
`
`§
`
`0
`
`9;
`
`<
`00
`N
`
`L9
`|--|
`L1.
`
`0 g
`
`"
`
`
`
`29
`
`
`
`
`
`m
`00
`N
`
`(9
`|--|
`LI_
`
`N
`
`8
`
`
`
`29
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 29 of 30
`
`US 2011/0218502 A1
`
`OmN.GE
`
`mom.mVE
`
`No:
`
`
`
`
`
`
`
`wove
`
`rm
`
`
`
`30
`
`30
`
`
`
`
`

`

`Patent Application Publication
`
`Sep. 8, 2011 Sheet 30 of 30
`
`US 2011/0218502 A1
`
`.9.
`
`Nor
`
`.munify
`
`mom.UE
`
`<om.UE
`
`Nov
`
`31
`
`31
`
`
`
`
`

`

`US 2011/0218502 A1
`
`Sep. 8, 2011
`
`CARRYING CASE AND SYRINGE SYSTEM
`WITH SAME
`
`TECHNICAL FIELD
`
`[0001] The present invention relates to a carrying case for a
`pharmaceutical injection device equipped with a pharmaceu-
`tical syringe containing a pharmaceutical for administering
`the pharmaceutical to a living body, and relates to a syringe
`system with the same.
`
`BACKGROUND ART
`
`[0002] Well-known carrying cases have been designed to
`accommodate and carry a predetermined article, equipment
`attached to the article, and the like. Some of the well-known
`carrying cases that have been commercially Viable so far
`include a type in which an accommodation section is entirely
`covered with a shock-absorbing material and a type in which
`such a shock-absorbing material is used as either a first shock-
`absorbing material or a second shock-absorbing material
`depending on situations.
`[0003]
`FIGS. 30A and 30B illustrate an exemplary well-
`known carrying case. FIG. 30A illustrates a top view of a
`carrying case 101, whereas FIG. 30B illustrates a side view of
`the carrying case 101. As illustrated in the figures, the carry-
`ing case 101 includes a case unit 102, an article holding
`portion 105 for accommodating an article 106, and a lid (not
`illustrated in the figure). Further, the case unit 102 includes a
`first shock-absorbing material 103 and a second shock-ab-
`sorbing material 104 in the inside thereof for protecting the
`article 106 from shocks (see e.g., Patent Literature 1).
`[0004] The carrying case 101 can thus mitigate shocks to be
`applied to the article 106.
`
`CITATION LIST
`
`Patent Literature
`
`Patent Literature 1: Specification of Japanese Patent
`[0005]
`No. 3010787
`
`SUMMARY
`
`Technical Problem
`
`[0006] However, when an article accommodated in the
`aforementioned well-known carrying case 101 is an elec-
`tronic device, an accurate instrument or the like requiring
`electrical power, a user is required to carry an electric charg-
`ing device (electric charger) with him/her for charging the
`device or the instrument, in addition to the carrying case.
`Therefore, a user is required to make the space for accommo-
`dating an electric charging device. Furthermore, it may some-
`times happen that a user may forget to bring the electric
`charging device with him/her.
`[0007] Meanwhile, the carrying case 101 does not include
`enough space to accommodate the other equipment and
`thereby cannot accommodate spare pharmaceuticals for
`which temperature control is required. The carrying case 101
`thereby lacks convenience.
`
`It is an object of the present invention to provide a
`[0008]
`carrying case and a syringe system for allowing a user to use
`a pharmaceutical injection device easily and safely.
`
`Solution to Problem
`
`[0009] A carrying case according to a first aspect of the
`present invention is a carrying case for a pharmaceutical
`injection device for administering a pharmaceutical to a liv-
`ing body and includes a case unit and an electric charging
`device. The case unit is configured to accommodate the phar-
`maceutical injection device therein. The electric charging
`device is mounted in the case unit. The electric charging
`device includes an electric charging terminal electrically con-
`nectable to the pharmaceutical injection device. The electric
`charging device is configured to electrically charge the phar-
`maceutical injection device.
`[0010] The following structure is adopted herein for the
`carrying case configured to accommodate the pharmaceutical
`injection device so that a user no longer needs to separately
`carry an electric charging device with him/her.
`[0011] The carrying case includes the case unit, and the
`electric charging device is mounted and fixed to the case unit
`for electrically charge the pharmaceutical injection device.
`The electric charging device includes the electric charging
`terminal electrically connectable to the pharmaceutical inj ec-
`tion device.
`
`[0012] The pharmaceutical injection device may be, for
`instance, an electronic device that accommodates a syringe
`containing a pharmaceutical and automatically injects the
`pharmaceutical into a living body. The aforementioned case
`unit may be a case unit that outlines the carrying case and
`includes, for instance, a pair of a bottom case and a cover
`connected to each other by means of a hinge in an openable/
`closable manner. “Electrically connectable” refers to a state
`that power supply is available, and may be a state that con-
`ductive members are connected to each other or a non-contact
`
`state using electromotive force or the like (by means of a
`non-contact electric charging method). The electric charging
`device includes, for instance, a power supply circuit for elec-
`tric charging, and may include a primary battery and/or an AC
`adaptor for supplying electric power to the power supply
`circuit, a jack for allowing an AC adaptor to be connected
`thereto, or the like.
`[0013] Well-known carrying cases for accommodating
`electronic devices (including portable electronic devices) and
`the like enclose shock-absorbing materials and the like for
`absorbing shocks. However, users are required to separately
`carry the electric charging devices for supplying electric
`power to the electronic devices. Therefore, users are required
`to secure the spaces for accommodating the electric charging
`devices and may forget to bring the electric charging devices
`with them in some cases.
`
`In view ofthe above, the carrying case ofthe present
`[0014]
`invention includes the electric charging device in the case
`unit.
`
`[0015] The structure allows a user to bring the pharmaceu-
`tical
`injection device and the electric charging device
`required for electrically charging the pharmaceutical injec-
`tion device while both of them are fixed to the carrying case.
`In other words, a user is allowed to bring an electric charging
`device and a pharmaceutical injection device in a single car-
`rying case.
`[0016] As a result, a user is no longer required to secure the
`space for accommodating an electric charging device in the
`
`32
`
`32
`
`

`

`US 2011/0218502 A1
`
`Sep. 8, 2011
`
`carrying case and separately carry an electric charging device
`with him/her, and the like. It is thereby possible to prevent
`such a situation that electric charging is not available when a
`user is out because he/she forgets to bring an electric charging
`device with him/her.
`
`[0017] A carrying case according to a second aspect of the
`present invention relates to the carrying case according to the
`first aspect of the present invention, in which the electric
`charging device includes a connector allowing an AC adaptor
`to be connected thereto.
`
`[0018] The connector may be, for instance, a plug-in jack,
`a connector mounted on a circuit board included in the elec-
`
`tric charging device, or the like.
`[0019]
`It is thereby possible to connect an external AC
`adaptor to the electric charging device or to accommodate an
`AC adaptor electrically connected to the electric charging
`device in the carrying case.
`[0020] As a result, the electric charging device is allowed to
`receive electric power from a commercial power source
`through an AC adaptor.
`[0021] A carrying case according to a third aspect of the
`present invention relates to the carrying case according to one
`of the first and second aspects of the present invention. In the
`carrying case, the electric charging device includes an AC
`adaptor. The AC adaptor is electrically connected to the con-
`nector.
`
`[0022] The electric charging device includes an AC adap-
`tor.
`
`Preferably, the AC adaptor has a plug portion pro-
`[0023]
`truded to the outside ofthe case unit. The plug portion may be
`configured to be protruded by means of a slide mechanism or
`the like.
`
`It is thereby possible to preliminarily include an AC
`[0024]
`adaptor in the carrying case. Therefore, a user is no longer
`required to separately carry an AC adaptor with him/her.
`[0025] As a result, it is possible to prevent a user from
`forgetting to bring an AC adaptor with him/her.
`[0026] A carrying case according to a fourth aspect of the
`present invention relates to the carrying case according to one
`of the first to third aspects of the present invention. In the
`carrying case, the electric charging device includes a primary
`battery.
`[0027] The electric charging device includes a primary bat-
`tery for electrically charging the pharmaceutical injection
`device.
`
`[0028] The primary battery herein refers to a battery that
`can supply electric power by itself.
`[0029]
`It is thereby possible to supply electric power for
`charging to the pharmaceutical injection device from the pri-
`mary battery without supplying electric power for charging
`thereto from the outside. Therefore, a user is allowed to
`execute electric charging of the pharmaceutical injection
`device even when he/she is in a place without a commercial
`power source or when he/she is moving. Further, the AC
`adaptor and the primary battery may be selectively used
`depending on situations.
`[0030] As a result, it is possible to provide a user-friendly
`carrying case with the electric charging function using a
`generally prevalent primary battery.
`[0031] A carrying case according to a fifth aspect of the
`present invention relates to the carrying case according to the
`first aspect or the fourth aspect ofthe present invention. In the
`carrying case,
`the electric charging device includes a
`
`rechargeable battery. The electric charging device is config-
`ured to electrically charge the rechargeable battery.
`[0032]
`It is thereby possible to more reliably supply electric
`power to the pharmaceutical injection device.
`[0033] A carrying case according to a sixth aspect of the
`present invention relates to the carrying case according to the
`first aspect of the present invention. In the carrying case, the
`electric charging device includes either a manual electric
`charging unit or a solar battery unit.
`[0034]
`It is thereby possible to more reliably supply electric
`power to the pharmaceutical injection device.
`[0035] A carrying case according to a seventh aspect of the
`present invention relates to the carrying case according to the
`fifth aspect of the present invention. In the carrying case, the
`electric charging device is configured to electrically charge
`either the pharmaceutical injection device or the rechargeable
`battery in a non-contact manner.
`[0036]
`It is thereby possible to more easily supply electric
`power to the pharmaceutical injection device.
`[0037] A carrying case according to an eighth aspect of the
`present invention relates to the carrying case according to one
`of the first to seventh aspects of the present invention. In the
`carrying case, the case unit includes a recess for accommo-
`dating the pharmaceutical
`injection device. The electric
`charging terminal of the electric charging device is protruded
`from the recess in a retractable manner.
`
`[0038] The electric charging terminal is protruded from the
`recess for accommodating the pharmaceutical
`injection
`device in a retractable manner.
`
`It is thereby possible to electrically connect a termi-
`[0039]
`nal receiver of the pharmaceutical injection device to the
`electric charging terminal while the pharmaceutical injection
`device is placed (accommodated) in the recess of the case
`unit. Therefore,
`the pharmaceutical
`injection device is
`allowed to be electrically charged while being accommodated
`in the case unit. The terminal receiver of the pharmaceutical
`injection device herein refers to a section allowing the electric
`charging terminal to be electrically connected thereto. The
`terminal receiver is electrically connected to a rechargeable
`battery (battery) provided in the pharmaceutical injection
`device.
`
`[0040] As a result, it is possible to provide a carrying case
`that allows a pharmaceutical injection device to be accom-
`modated therein and to be electrically charged easily.
`[0041] A carrying case according to a ninth aspect of the
`present invention relates to the carrying case according to the
`eighth aspect ofthe present invention. In the carrying case, the
`electric charging device includes an elastic member attached
`to the electric charging terminal and configured to urge the
`electric charging terminal to be protruded from the top of the
`recess of the case unit.
`
`[0042] Examples of the elastic member include a metal
`spring such as a coil spring, a resin spring such as urethane
`and rubber, or other members made of material with elastic-
`ity.
`It is thereby possible to eliminate variation in sizes
`[0043]
`among the pharmaceutical injection device, the case unit and
`the electric charging device when the terminal receiver of the
`pharmaceutical injection device and the electric charging ter-
`minal of the electric charging device make contact with each
`other. Therefore, the electric charging terminal and the termi-
`nal receiver are allowed to reliably make contact with each
`other while the pharmaceutical injection device is accommo-
`dated in the recess of the case unit.
`
`33
`
`33
`
`

`

`US 2011/0218502 A1
`
`Sep. 8, 2011
`
`[0044] As a result, it is possible to prevent a failure of
`electric charging due to loose connection and avoid troubles
`such as shortage of electric power in use.
`[0045] A carrying case according to a tenth aspect of the
`present invention relates to the carrying case according to the
`first aspect of the present invention. In the carrying case, the
`case unit includes an openable/closable pair of a cover and a
`bottom case. The electric charging device is configured to
`stop or start electric charging in conjunction with an opening
`or a closing action of the cover and the bottom case.
`[0046] Electric charging is allowed to be stopped or started
`in conjunction with an opening action or a closing action of
`the case unit. Therefore,
`it
`is possible to automatically
`execute an electric charging operation without making a user
`aware of it.
`
`[0047] A carrying case according to an eleventh aspect of
`the present invention relates to the carrying case according to
`the first aspect of the present invention. The carrying case
`further includes a display unit.
`[0048]
`It is thereby possible to enhance convenience of the
`carrying case.
`[0049] A carrying case according to a twelfth aspect of the
`present invention relates to the carrying case according to the
`eleventh aspect of the present invention. In the carrying case,
`the display unit is configured to execute a display operation
`using a liquid crystal, an organic EL or an LED.
`[0050] A carrying case according to a thirteenth aspect of
`the present invention relates to the carrying case according to
`the eleventh aspect or the twelfth aspect of the present inven-
`tion. In the carrying case, the display unit is configured to
`display an electric charging status, a data communication
`status, a conduction status or error content.
`[0051] A carrying case according to a fourteenth aspect of
`the present invention relates to the carrying case according to
`the thirteenth aspect of the present invention. In the carrying
`case, the display unit is configured to display, as the electric
`charging status, a remainder frequency of pharmaceutical
`injections by the pharmaceutical injection device.
`[0052] A carrying case according to a fifteenth aspect ofthe
`present invention relates to the carrying case according to the
`first aspect ofthe present invention. The carrying case further
`includes at least either ofan audio unit and a vibration unit. At
`
`least either ofthe audio unit and vibration unit is configured to
`inform a user of predetermined information by means of an
`audio guide, an alert buzzer or a vibration.
`[0053] The predetermined information herein refers to a
`current status ofthe carrying case such as an electric charging
`status, a communication status, a conduction status, warning,
`caution or the like (e.g., the remaining available number of
`times for injections by the pharmaceutical injection device
`based on the amount of injected pharmaceutical agent). The
`audio unit is configured to inform a user of the predetermined
`information by means of a buzzer, a sounder, a speaker or the
`like. The vibration unit is configured to cause a vibrator or the
`like to generate vibrations in the carrying case and thereby
`inform a user of the predetermined information.
`[0054]
`It is thereby possible to inform a visually and/or
`auditory disabled user of information. Therefore, it is pos-
`sible to enhance convenience and safety of the carrying case.
`[0055] A carrying case according to a sixteenth aspect of
`the present invention relates to the carrying case according to
`the first aspect of the present invention. The carrying case
`further includes an input unit configured to receive an infor-
`mation input by a user.
`
`[0056] The input unit herein may be built in the carrying
`case or an external input unit.
`[0057] A carrying case according to a seventeenth aspect of
`the present invention relates to the carrying case according to
`the first aspect of the present invention. In the carrying case,
`the case unit further includes a lock mechanism. The lock
`
`mechanism is configured to secure the pharmaceutical inj ec-
`tion device to the case unit such that the electric charging
`terminal of the electric charging device makes contact with a
`terminal receiver of the pharmaceutical injection device.
`[0058] The lock mechanism herein secures the pharmaceu-
`tical injection device to the electric charging device.
`[0059]
`For example, it is possible to use, as the lock mecha-
`nism, an engaging member configured to secure the electric
`charging device and the pharmaceutical inj ection device with
`each other by the electric charging device engaging with a
`part ofthe pharmaceutical injection device. When the electric
`charging terminal
`is protruded from the recess, the lock
`mechanism is preferably disposed such that the pharmaceu-
`tical injection device is secured to the recess.
`[0060]
`It is thereby possible to reliably secure the pharma-
`ceutical
`injection device to the electric charging device.
`When the electric charging terminal is protruded from the
`recess, the pharmaceutical injection device can be reliably in
`contact with and fixed to the electric charging device while
`being secured to the recess.
`[0061] As a result, the pharmaceutical injection device can
`be prevented from being removed from the electric charging
`device due to vibrations or shocks. Therefore, the pharma-
`ceutical injection device can be reliably electrically charged.
`[0062] A carrying case according to an eighteenth aspect of
`the present invention relates to the carrying case according to
`the first aspect of the present invention. In the carrying case,
`the case unit includes an openable/closable pair of a cover and
`a bottom case. The cover includes a transparent window por-
`tion, a translucent window portion or a cutout window por-
`tion.
`
`[0063] The carrying case is divided into a cover and a
`bottom case. The cover is provided with a window portion for
`allowing a user to check whether or not the pharmaceutical
`injection device is accommodated in the carrying case.
`[0064] The cover and the bottom case are preferably con-
`nected to each other by means of, for instance, a hinge or the
`like. For example, a transparent plastic, glass or the like may
`be used for the window portion.
`[0065]
`It is thereby possible for a user to visually check the
`inside of the carrying case through the window portion.
`Therefore, a user is allowed to easily check whether or not the
`pharmaceutical injection device is accommodated in the car-
`rying case.
`[0066] As a result, it is possible to prevent a user from
`forgetting to put the pharmaceutical injection device in the
`carrying case.
`[0067] A carrying case according to a nineteenth aspect of
`the present invention relates to the carrying case according to
`the eighteenth aspect of the present invention. In the carrying
`case, the bottom case includes an engaging mechanism. The
`engaging mechanism is configured to engage with the cover
`when the cover is in a closed state.
`
`Preferably, the engaging mechanism is, for instance,
`[0068]
`a slide knob including a slide mechanism or the like.
`[0069]
`It is thereby possible to control opening and closing
`of the cover and the bottom case. Therefore, it is possible to
`prevent the carrying case from being accidentally opened.
`34
`
`34
`
`

`

`US 2011/0218502 A1
`
`Sep. 8, 2011
`
`[0070] As a result, a user can safely carry the carrying case
`with him/her.
`
`[0071] A carrying case according to a twentieth aspect of
`the present invention relates to the carrying case according to
`the eighteenth aspect or the nineteenth aspect of the present
`invention. In the carrying case, the cover includes an equip-
`ment presser rib. The equipment presser rib is configured to
`hold equipment for the pharmaceutical injection device to be
`accommodated in the bottom case.
`
`[0072] The cover is provided with the equipment presser rib
`for holding equipment necessary for the pharmaceutical
`injection device.
`[0073] The equipment includes a needle to be used for the
`pharmaceutical
`injection device, a spare pharmaceutical
`syringe and the like. The bottom case is preferably provided
`with an equipment accommodation portion for accommodat-
`ing the aforementioned equipment.
`[0074] The equipment can be thereby held while the cover
`is closed. Therefore, the equipment can be prevented from
`being scattered in the carrying case.
`[0075] As a result, it is possible to provide a carrying case
`that is more user-friendly than well-known carrying cases.
`[0076] A carrying case according to a twenty-first aspect of
`the present invention relates to the carrying case according to
`one of the eighteenth to twentieth aspects of the present
`invention. In the carrying case, the cover includes a first
`shock-absorbing member in an inner side thereof for protect-
`ing the pharmaceutical injection device.
`[0077] The shock-absorbing member includes a material
`for absorbing shocks, and may be made of rubber.
`[0078] Even when the pharmaceutical injection device col-
`lides against the inside of the cover when the carrying case is
`in a closed state, shocks can be mitigated.
`[0079] As a result, it is possible to provide the carrying case
`for protecting the pharmaceutical injection device from being
`damaged or broken.
`[0080] A carrying case according to a twenty-second aspect
`ofthe present invention relates to the carrying case according
`to one of the first to twenty-first aspects of the present inven-
`tion.
`In the carrying case,
`the electric charging device
`includes a second shock-absorbing member for protecting
`electronic components included in the electric charging
`device from shocks.
`
`It is thereby possible to protect a primary battery, a
`[0081]
`power supply circuit or the like included in the electric charg-
`ing device from shocks.
`[0082] A carrying case according to a twenty-third aspect
`of the present invention is a carrying case configured to
`accommodate a pharmaceutical injection device for admin-
`istering a pharmaceutical to a living body. The carrying case
`includes: a case unit accommodating the pharmaceutical
`injection device therein; and a temperature regulation unit
`configured to regulate a temperature within the case unit. The
`temperature regulation unit includes: a cooling execution sec-
`tion configured to execute a cooling operation; a cooling fan
`configured to supply a cool air into the case unit; and a cooling
`control section configured to control the cooling execution
`section.
`
`[0083] The carrying case includes the temperature regula-
`tion unit and a cool air is supplied to the inside ofthe case unit
`by controlling and executing a cooling operation. Accord-
`ingly, a user is allowed to carry the pharmaceutical that
`
`requires a temperature control with him/her using the carry-
`ing case. Therefore, it is possible to enhance safety and con-
`venience of the carrying case.
`[0084] A carrying case according to a twenty-fourth aspect
`ofthe present invention relates to the carrying case according
`to the twenty-third aspect of the present invention. In the
`carrying case, the case unit further includes at least one tem-
`perature sensor. The cooling control se